Sign in
TerminatedNo phase

Maintenance TMS in Treatment Resistant Depression

Key facts

Who runs it
Austin Messner
Where
Lexington, United StatesSee the site
Trial code
Status
Terminated
People taking part
1 person enrolled
Started
17 Apr 2025
Ended
26 Jun 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Transmagnetic Stimulation
  • Electroconvulsive Therapy
Record updated
12 May 2026
Why it stopped
Lack of enrollment

Who can take part

Age
18 years to 65 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Patients treated for TRD who have achieved remission through an index series of ECT
  • Able to provide informed consent
  • Age between 18 and 65 years
  • Deemed appropriate for maintenance TMS by their psychiatrist
  • Right-handed

Who cannot take part

  • History of seizures or a seizure disorder
  • Related neurological disorder, or any other medical condition that would preclude TMS treatment determined by the treatment team

Where in United States

  • University of KentuckyLexington, United States

About the trial

What the trial wants to find out

Electroconvulsive therapy (ECT) is one of the most efficacious treatments available for treatment-resistant depression (TRD). Although a maintenance ECT protocol exists, multiple barriers limit its use for long-term use. These barriers include procedure tolerability, cognitive side effects, financial burden, and unreliable social support to accompany patients for these treatments. On the other hand, a different modality of noninvasive neuromodulation called transcranial magnetic stimulation (TMS) can be performed in the outpatient setting and does not need anesthesia. The likelihood of cognitive adverse effects with TMS is much lower than with ECT. Our clinical question encompasses piloting a maintenance TMS regimen to maintain remission in treatment-resistant major depressive disorder.

Read full original descriptionShow less

This will be a patient-preference clinical trial, with patients offered the choice to initiate maintenance TMS versus maintenance ECT after their index ECT sessions for treatment-resistant depression. There will be no randomization or placebo involved in this study.

The 2 groups in the trial

  • TMSTreatment being tested

    Patients who have achieved remission of treatment resistant depression through an initial course of ECT (8 to 12 sessions) at the University of Kentucky will be identified by the ECT attending physician as a candidate for this study. They will receive TMS in this arm of study for maintenance treatment of their depression and monitored with depressive scales.

    Treatment: Transmagnetic Stimulation

  • ECTExisting treatment, for comparison

    Patients who have achieved remission of treatment resistant depression through an initial course of ECT (8 to 12 sessions) at the University of Kentucky will be identified by the ECT attending physician as a candidate for this study. If they elect to continue with maintenance ECT treatments which is the current standard of care, their depressive symptoms and cognitive functioning will be monitored accordingly.

    Treatment: Electroconvulsive Therapy

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Transitioning From Maintenance ECT to Maintenance TMS in Treatment Resistant Depression
Record updated
12 May 2026